Protagonist Therapeutics, Inc. (PTGX)
82.76
-0.33
(-0.40%)
USD |
NASDAQ |
Feb 20, 16:00
82.77
+0.01
(+0.01%)
After-Hours: 20:00
Protagonist Therapeutics Market Cap : 5.174B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 584.38B |
| ADMA Biologics, Inc. | 3.832B |
| Glaukos Corp. | 6.908B |
| Krystal Biotech, Inc. | 7.592B |
| ACADIA Pharmaceuticals, Inc. | 4.059B |
Market Cap Related Metrics
| PE Ratio | 130.68 |
| PS Ratio | 25.38 |
| Price to Book Value | 8.016 |
| Price to Free Cash Flow | 83.35 |
| Price | 82.76 |
| Earnings Yield | 0.77% |
| Operating PE Ratio | 279.36 |
| Normalized PE Ratio | 130.66 |